Implications for employers: This research suggests that those who are treated effectively with GLP-1 medications for obesity will need to remain on these for the long term
The increase in risk was small approximately three to four additional cases per 10,000 patients treated with GLP-1s over 18 months, but clinicians and patients should be aware of this potential association. Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety
They work by slowing stomach emptying, regulating appetite, and influencing reward pathways in the brain
The Nutrition Coach team is prepared to discuss general health topics, including nutrition, diet, and lifestyle as well as optimal nutrient blends, product comparisons, and general nutrition recommendations for health goals like joint health, bone health, and healthy aging.** To learn more about Puritan's Pride, its new supplement bundles and Ask a Nutrition Coach offering, please visit www.puritan.com or call 1-800-645-1030
It often takes reaching a higher, therapeutic dose before significant weight loss begins
Answer those, and the right solution becomes obvious